Novartis Strikes a $3.1 Billion Deal to Acquire Anthos Therapeutics

Novartis AG has agreed to acquire Anthos Therapeutics for up to $3.1 billion, with an upfront payment of $925 million and additional milestone-based payments. The deal, expected to...